103 related articles for article (PubMed ID: 23812298)
41. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
[TBL] [Abstract][Full Text] [Related]
42. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.
Gharavi NM; Gargalovic PS; Chang I; Araujo JA; Clark MJ; Szeto WL; Watson AD; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1346-53. PubMed ID: 17379837
[TBL] [Abstract][Full Text] [Related]
43. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome.
Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW
J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684
[TBL] [Abstract][Full Text] [Related]
44. Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways.
Huang CY; Lin FY; Shih CM; Au HK; Chang YJ; Nakagami H; Morishita R; Chang NC; Shyu KG; Chen JW
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2405-17. PubMed ID: 22904272
[TBL] [Abstract][Full Text] [Related]
45. Endothelial and antithrombotic actions of HDL.
Mineo C; Deguchi H; Griffin JH; Shaul PW
Circ Res; 2006 Jun; 98(11):1352-64. PubMed ID: 16763172
[TBL] [Abstract][Full Text] [Related]
46. The anti-oxidative capacity of high-density lipoprotein is reduced in acute coronary syndrome but not in stable coronary artery disease.
Patel PJ; Khera AV; Jafri K; Wilensky RL; Rader DJ
J Am Coll Cardiol; 2011 Nov; 58(20):2068-75. PubMed ID: 22051328
[TBL] [Abstract][Full Text] [Related]
47. The HDL proteome in acute coronary syndromes shifts to an inflammatory profile.
Alwaili K; Bailey D; Awan Z; Bailey SD; Ruel I; Hafiane A; Krimbou L; Laboissiere S; Genest J
Biochim Biophys Acta; 2012 Mar; 1821(3):405-15. PubMed ID: 21840418
[TBL] [Abstract][Full Text] [Related]
48. Impact of different training modalities on high-density lipoprotein function in HFpEF patients: a substudy of the OptimEx trial.
Sowa PW; Winzer EB; Hommel J; Männel A; van Craenenbroeck EM; Wisløff U; Pieske B; Halle M; Linke A; Adams V
ESC Heart Fail; 2022 Oct; 9(5):3019-3030. PubMed ID: 35747946
[TBL] [Abstract][Full Text] [Related]
49. Plasma cholesterol homeostasis, HDL remodeling and function during the acute phase reaction.
Zimetti F; De Vuono S; Gomaraschi M; Adorni MP; Favari E; Ronda N; Ricci MA; Veglia F; Calabresi L; Lupattelli G
J Lipid Res; 2017 Oct; 58(10):2051-2060. PubMed ID: 28830907
[TBL] [Abstract][Full Text] [Related]
50. PON-dering differences in HDL function in coronary artery disease.
Mineo C; Shaul PW
J Clin Invest; 2011 Jul; 121(7):2545-8. PubMed ID: 21701074
[TBL] [Abstract][Full Text] [Related]
51. Impact of Lifestyle Intervention on HDL-Induced eNOS Activation and Cholesterol Efflux Capacity in Obese Adolescent.
Wesnigk J; Bruyndonckx L; Hoymans VY; De Guchtenaere A; Fischer T; Schuler G; Vrints CJ; Adams V
Cardiol Res Pract; 2016; 2016():2820432. PubMed ID: 27965912
[No Abstract] [Full Text] [Related]
52. Defective Allele of the Neuronal Nitric Oxide Synthase Gene Increases Insulin Resistance During Acute Phase of Myocardial Infarction.
Nóbrega OT; Campos-Staffico AM; Oliveira EK; Munhoz DB; Moura FA; Carvalho LSF; Soares AASM; Gomes CM; Tonet-Furioso AC; Sposito AC;
Int J Gen Med; 2021; 14():3669-3676. PubMed ID: 34321912
[TBL] [Abstract][Full Text] [Related]
53. [Research progress in the modulating effect of high-density lipoprotein on neutrophil function].
Wang ZZ; Xiang H; Xia SL; Shang D
Sheng Li Xue Bao; 2017 Dec; 69(6):852-860. PubMed ID: 29270601
[TBL] [Abstract][Full Text] [Related]
54. Lipoproteins in inflammation and sepsis. I. Basic science.
Murch O; Collin M; Hinds CJ; Thiemermann C
Intensive Care Med; 2007 Jan; 33(1):13-24. PubMed ID: 17093985
[TBL] [Abstract][Full Text] [Related]
55. HDL Particle Size and Functionality Comparison between Patients with and without Confirmed Acute Myocardial Infarction.
de Miranda Teixeira R; Cruz de Sá N; Caires Dos Santos AP; Anjos E Silva VR; de Magalhães Cabral Albuquerque EC; Lemos Correia LC; Couto RD
Cardiol Res Pract; 2019; 2019():3074602. PubMed ID: 30944734
[TBL] [Abstract][Full Text] [Related]
56. Modulation of High-Density Lipoprotein Function via Cardiac Rehabilitation.
Satomi-Kobayashi S; Ishida T
J Atheroscler Thromb; 2018 Feb; 25(2):128-130. PubMed ID: 29142155
[No Abstract] [Full Text] [Related]
57. High-density lipoprotein and cardiac glucose metabolism: Implications for management of acute coronary syndromes.
Richart AL; Heywood SE; Siebel AL; Kingwell BA
Eur J Prev Cardiol; 2018 Feb; 25(3):273-275. PubMed ID: 29239221
[No Abstract] [Full Text] [Related]
58. Acute coronary syndromes: Myocardial salvage with HDL infusion after infarction.
Lim GB
Nat Rev Cardiol; 2017 Dec; 14(12):695. PubMed ID: 29072254
[No Abstract] [Full Text] [Related]
59. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations.
Ponnaiah M; Zakiev E; Lhomme M; Rached F; Camont L; Serrano CV; Santos RD; Chapman MJ; Orekhov A; Kontush A
Atheroscler Plus; 2024 Mar; 55():21-30. PubMed ID: 38226021
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
